Success Metrics

Clinical Success Rate
85.2%

Based on 23 completed trials

Completion Rate
85%(23/27)
Active Trials
18(34%)
Results Posted
52%(12 trials)
Terminated
4(8%)

Phase Distribution

Ph phase_4
1
2%
Ph phase_1
4
8%
Ph phase_2
20
38%
Ph early_phase_1
1
2%
Ph not_applicable
14
26%
Ph phase_3
9
17%

Phase Distribution

5

Early Stage

20

Mid Stage

10

Late Stage

Phase Distribution49 total trials
Early Phase 1First-in-human
1(2.0%)
Phase 1Safety & dosage
4(8.2%)
Phase 2Efficacy & side effects
20(40.8%)
Phase 3Large-scale testing
9(18.4%)
Phase 4Post-market surveillance
1(2.0%)
N/ANon-phased studies
14(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.1%

23 of 28 finished

Non-Completion Rate

17.9%

5 ended early

Currently Active

18

trials recruiting

Total Trials

53

all time

Status Distribution
Active(20)
Completed(23)
Terminated(5)
Other(5)

Detailed Status

Completed23
Recruiting14
unknown5
Terminated4
Active, not recruiting4
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
53
Active
18
Success Rate
85.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.0%)
Phase 14 (8.2%)
Phase 220 (40.8%)
Phase 39 (18.4%)
Phase 41 (2.0%)
N/A14 (28.6%)

Trials by Status

terminated48%
unknown59%
recruiting1426%
withdrawn12%
active_not_recruiting48%
completed2343%
not_yet_recruiting24%

Recent Activity

Clinical Trials (53)

Showing 20 of 53 trialsScroll for more
NCT05957510Phase 2

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

Recruiting
NCT07111520Phase 1

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Recruiting
NCT05985655Phase 1

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Recruiting
NCT07371429Phase 1

A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics

Not Yet Recruiting
NCT07340541Phase 2

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Recruiting
NCT06831955Phase 2

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Recruiting
NCT05483283Not Applicable

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care

Recruiting
NCT04337450Phase 2

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Active Not Recruiting
NCT05332613Not Applicable

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

Recruiting
NCT04935697Not Applicable

Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress

Completed
NCT06315530Phase 2

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Completed
NCT06987968Phase 2

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

Terminated
NCT05205967

REFLECTION: A Clinical Practice Learning Program for Galleri®

Active Not Recruiting
NCT06085924

A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.

Completed
NCT07059975Early Phase 1

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Recruiting
NCT06736171Not Applicable

Post Stroke Ambulation Recovery Using Robotic Exoskeletons

Recruiting
NCT01950247Phase 4

Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron

Completed
NCT05884190Not Applicable

Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension

Recruiting
NCT02954458Phase 3

Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

Completed
NCT02949362Phase 3

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Completed

Drug Details

Intervention Type
DRUG
Total Trials
53